Published in J Tissue Eng Regen Med on July 01, 2009
Materials fabrication from Bombyx mori silk fibroin. Nat Protoc (2011) 3.45
A region of the human HOXD cluster that confers polycomb-group responsiveness. Cell (2010) 3.27
Identification and clonal characterisation of a progenitor cell sub-population in normal human articular cartilage. PLoS One (2010) 1.50
Mechanics and mechanobiology of mesenchymal stem cell-based engineered cartilage. J Biomech (2009) 1.29
Engineered cartilage using primary chondrocytes cultured in a porous cartilage-derived matrix. Regen Med (2011) 1.03
Epigenetic and phenotypic profile of fibroblasts derived from induced pluripotent stem cells. PLoS One (2011) 1.01
Genipin-crosslinked cartilage-derived matrix as a scaffold for human adipose-derived stem cell chondrogenesis. Tissue Eng Part A (2012) 1.01
Effect of initial cell seeding density on 3D-engineered silk fibroin scaffolds for articular cartilage tissue engineering. Biomaterials (2011) 0.95
Variable requirements for DNA-binding proteins at polycomb-dependent repressive regions in human HOX clusters. Mol Cell Biol (2013) 0.93
Comparison between Chondrogenic Markers of Differentiated Chondrocytes from Adipose Derived Stem Cells and Articular Chondrocytes In Vitro. Iran J Basic Med Sci (2013) 0.92
Fibroblasts derived from human embryonic stem cells direct development and repair of 3D human skin equivalents. Stem Cell Res Ther (2011) 0.91
A comparative study of aggrecan synthesis between natural articular chondrocytes and differentiated chondrocytes from adipose derived stem cells in 3D culture. Adv Biomed Res (2012) 0.85
Isolation, characterization, and differentiation of stem cells for cartilage regeneration. Ann Biomed Eng (2012) 0.84
Informing future cartilage repair strategies: a comparative study of three different human cell types for cartilage tissue engineering. Cell Tissue Res (2013) 0.84
The role of growth factors in stem cell-directed chondrogenesis: a real hope for damaged cartilage regeneration. Int Orthop (2014) 0.83
Silk-fibrin/hyaluronic acid composite gels for nucleus pulposus tissue regeneration. Tissue Eng Part A (2011) 0.83
Directed differentiation of induced pluripotent stem cells into chondrogenic lineages for articular cartilage treatment. J Tissue Eng (2014) 0.80
Chondrocyte source for cartilage regeneration in an immature animal: Is iliac apophysis a good alternative? Indian J Orthop (2012) 0.79
The use of mesenchymal stem cells for cartilage repair and regeneration: a systematic review. J Orthop Surg Res (2017) 0.79
Osteochondral tissue engineering in vivo: a comparative study using layered silk fibroin scaffolds from mulberry and nonmulberry silkworms. PLoS One (2013) 0.78
Fabrication and characterization of spongy denuded amniotic membrane based scaffold for tissue engineering. Cell J (2015) 0.77
Polyester type polyHIPE scaffolds with an interconnected porous structure for cartilage regeneration. Sci Rep (2016) 0.76
Chitosan feasibility to retain retinal stem cell phenotype and slow proliferation for retinal transplantation. Biomed Res Int (2014) 0.75
Treatment of chronic posttraumatic leg injury using autologous fat graft. Case Rep Med (2012) 0.75
Isolation and characterization of human articular chondrocytes from surgical waste after total knee arthroplasty (TKA). PeerJ (2017) 0.75
Multilineage potential of adult human mesenchymal stem cells. Science (1999) 66.19
Embryonic stem cell lines derived from human blastocysts. Science (1998) 65.53
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy (2006) 37.55
Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng (2001) 20.65
Tissue engineering. Science (1993) 19.65
Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med (1994) 14.46
Mesenchymal stem cells. J Orthop Res (1991) 10.98
Silk-based biomaterials. Biomaterials (2003) 7.72
Porosity of 3D biomaterial scaffolds and osteogenesis. Biomaterials (2005) 7.55
Dedifferentiated chondrocytes reexpress the differentiated collagen phenotype when cultured in agarose gels. Cell (1982) 6.61
Three-dimensional aqueous-derived biomaterial scaffolds from silk fibroin. Biomaterials (2005) 3.87
Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers. Biomaterials (1996) 3.66
Mesenchymal cell-based repair of large, full-thickness defects of articular cartilage. J Bone Joint Surg Am (1994) 3.62
Relationship between cell shape and type of collagen synthesised as chondrocytes lose their cartilage phenotype in culture. Nature (1977) 3.46
Chondrogenic differentiation of mesenchymal stem cells from bone marrow: differentiation-dependent gene expression of matrix components. Exp Cell Res (2001) 3.06
Application of chitosan-based polysaccharide biomaterials in cartilage tissue engineering: a review. Biomaterials (2000) 2.83
Comparison of rat mesenchymal stem cells derived from bone marrow, synovium, periosteum, adipose tissue, and muscle. Cell Tissue Res (2006) 2.79
Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees. Osteoarthritis Cartilage (2002) 2.78
Adult mesenchymal stem cells and cell-based tissue engineering. Arthritis Res Ther (2002) 2.63
In vitro chondrogenesis of bone marrow-derived mesenchymal stem cells in a photopolymerizing hydrogel. Tissue Eng (2003) 2.05
In vitro cartilage tissue engineering with 3D porous aqueous-derived silk scaffolds and mesenchymal stem cells. Biomaterials (2005) 2.02
Neocartilage formation in vitro and in vivo using cells cultured on synthetic biodegradable polymers. J Biomed Mater Res (1993) 1.88
Cartilage-like gene expression in differentiated human stem cell spheroids: a comparison of bone marrow-derived and adipose tissue-derived stromal cells. Arthritis Rheum (2003) 1.84
Do adipose tissue-derived mesenchymal stem cells have the same osteogenic and chondrogenic potential as bone marrow-derived cells? Osteoarthritis Cartilage (2005) 1.83
BMP-6 enhances chondrogenesis in a subpopulation of human marrow stromal cells. Biochem Biophys Res Commun (2001) 1.80
Reduced chondrogenic potential of adipose tissue derived stromal cells correlates with an altered TGFbeta receptor and BMP profile and is overcome by BMP-6. J Cell Physiol (2007) 1.79
Mesenchymal stem cell aging. Exp Gerontol (2005) 1.79
Chondrogenic differentiation of human embryonic stem cell-derived cells in arginine-glycine-aspartate-modified hydrogels. Tissue Eng (2006) 1.72
Growth factor combination for chondrogenic induction from human mesenchymal stem cell. Biochem Biophys Res Commun (2004) 1.72
Cartilage tissue engineering with silk scaffolds and human articular chondrocytes. Biomaterials (2006) 1.67
Potent induction of chondrocytic differentiation of human adipose-derived adult stem cells by bone morphogenetic protein 6. Arthritis Rheum (2006) 1.56
Elucidating the secretion proteome of human embryonic stem cell-derived mesenchymal stem cells. Mol Cell Proteomics (2007) 1.51
Cartilage-like tissue engineering using silk scaffolds and mesenchymal stem cells. Tissue Eng (2006) 1.45
Chitosan supports the expression of extracellular matrix proteins in human osteoblasts and chondrocytes. J Biomed Mater Res (2000) 1.43
Evaluation of adult equine bone marrow- and adipose-derived progenitor cell chondrogenesis in hydrogel cultures. J Orthop Res (2008) 1.43
Chondrogenesis in a cell-polymer-bioreactor system. Exp Cell Res (1998) 1.42
Cultivation of human embryonic stem cells without the embryoid body step enhances osteogenesis in vitro. Stem Cells (2005) 1.38
Characterization of a pluripotent stem cell line derived from a mouse embryo. Exp Cell Res (1984) 1.36
A comparison between the chondrogenic potential of human bone marrow stem cells (BMSCs) and adipose-derived stem cells (ADSCs) taken from the same donors. Tissue Eng (2007) 1.22
Stem cell characteristics of human trabecular bone-derived cells. Bone (2002) 1.21
Tissue engineering with chondrogenically differentiated human embryonic stem cells. Stem Cells (2007) 1.17
Direct selection of human bone marrow mesenchymal stem cells using an anti-CD49a antibody reveals their CD45med,low phenotype. Br J Haematol (2003) 1.16
Resorbable polyesters in cartilage engineering: affinity and biocompatibility of polymer fiber structures to chondrocytes. J Biomed Mater Res (1996) 1.13
GAG-augmented polysaccharide hydrogel: a novel biocompatible and biodegradable material to support chondrogenesis. J Biomed Mater Res (2000) 1.12
Transgene-activated mesenchymal cells for articular cartilage repair: a comparison of primary bone marrow-, perichondrium/periosteum- and fat-derived cells. J Gene Med (2006) 1.04
Bone and cartilage formation by skeletal muscle derived cells. J Cell Physiol (2005) 1.02
Effects of serial expansion of septal chondrocytes on tissue-engineered neocartilage composition. Otolaryngol Head Neck Surg (2002) 1.01
In vitro characterization of chitosan scaffolds: influence of composition and deacetylation degree. J Mater Sci Mater Med (2007) 1.00
Growth factors for clinical-scale expansion of human articular chondrocytes: relevance for automated bioreactor systems. Tissue Eng (2007) 0.99
Novel gene-modified-tissue engineering of cartilage using stable transforming growth factor-beta1-transfected mesenchymal stem cells grown on chitosan scaffolds. J Biosci Bioeng (2007) 0.93
Biopolymer-based biomaterials as scaffolds for tissue engineering. Adv Biochem Eng Biotechnol (2006) 0.92
Critical Steps toward a tissue-engineered cartilage implant using embryonic stem cells. Tissue Eng Part A (2008) 0.92
Chitosan particles agglomerated scaffolds for cartilage and osteochondral tissue engineering approaches with adipose tissue derived stem cells. J Mater Sci Mater Med (2005) 0.92
Porous methacrylate scaffolds: supercritical fluid fabrication and in vitro chondrocyte responses. Biomaterials (2004) 0.90
Analysis of cartilage maturation using micromass cultures of primary chondrocytes. Dev Growth Differ (2000) 0.89
Recent advances in biomaterials. Yonsei Med J (1998) 0.89
Differentiation potential of human embryonic mesenchymal stem cells for skin-related tissue. Br J Dermatol (2006) 0.87
Culture of chondrocytes in fibroin-hydrogel sponge. Biomed Mater Eng (2003) 0.86
Tissue engineering of cartilage: do we need it, can we do it, is it good and can we prove it? Novartis Found Symp (2003) 0.80
Neocartilage formation from predifferentiated human adipose derived stem cells in vivo. Acta Pharmacol Sin (2007) 0.79
Proteoglycan core protein and type II collagen gene expressions are not correlated with cell shape changes during low density chondrocyte cultures. Differentiation (1990) 0.79
Silk-based biomaterials. Biomaterials (2003) 7.72
Mechanism of silk processing in insects and spiders. Nature (2003) 4.85
Dissolvable films of silk fibroin for ultrathin conformal bio-integrated electronics. Nat Mater (2010) 4.62
A TALEN genome-editing system for generating human stem cell-based disease models. Cell Stem Cell (2012) 4.49
Silk as a Biomaterial. Prog Polym Sci (2007) 4.13
New opportunities for an ancient material. Science (2010) 3.95
Three-dimensional aqueous-derived biomaterial scaffolds from silk fibroin. Biomaterials (2005) 3.87
Distinct molecular mechanism for initiating TRAF6 signalling. Nature (2002) 3.82
In vitro degradation of silk fibroin. Biomaterials (2005) 3.56
Materials fabrication from Bombyx mori silk fibroin. Nat Protoc (2011) 3.45
In vivo degradation of three-dimensional silk fibroin scaffolds. Biomaterials (2008) 3.39
A region of the human HOXD cluster that confers polycomb-group responsiveness. Cell (2010) 3.27
Electrospun silk-BMP-2 scaffolds for bone tissue engineering. Biomaterials (2006) 3.27
Villification: how the gut gets its villi. Science (2013) 2.94
Stem cell-based tissue engineering with silk biomaterials. Biomaterials (2006) 2.88
The inflammatory responses to silk films in vitro and in vivo. Biomaterials (2005) 2.79
Porous 3-D scaffolds from regenerated silk fibroin. Biomacromolecules (2004) 2.77
High-efficiency RNA interference in human embryonic stem cells. Stem Cells (2005) 2.76
A murine ESC-like state facilitates transgenesis and homologous recombination in human pluripotent stem cells. Cell Stem Cell (2010) 2.65
Cell differentiation by mechanical stress. FASEB J (2001) 2.56
Structure and properties of silk hydrogels. Biomacromolecules (2004) 2.50
A call for standardized naming and reporting of human ESC and iPSC lines. Cell Stem Cell (2011) 2.48
A physically transient form of silicon electronics. Science (2012) 2.47
Clinical correlates in an experimental model of repetitive mild brain injury. Ann Neurol (2013) 2.32
Vascularization strategies for tissue engineering. Tissue Eng Part B Rev (2009) 2.31
Regulation of silk material structure by temperature-controlled water vapor annealing. Biomacromolecules (2011) 2.24
Silk matrix for tissue engineered anterior cruciate ligaments. Biomaterials (2002) 2.22
Waterproof AlInGaP optoelectronics on stretchable substrates with applications in biomedicine and robotics. Nat Mater (2010) 2.20
Electrospinning Bombyx mori silk with poly(ethylene oxide). Biomacromolecules (2002) 2.20
Sonication-induced gelation of silk fibroin for cell encapsulation. Biomaterials (2007) 2.15
Engineering adipose-like tissue in vitro and in vivo utilizing human bone marrow and adipose-derived mesenchymal stem cells with silk fibroin 3D scaffolds. Biomaterials (2007) 2.13
Macrophage responses to silk. Biomaterials (2003) 2.04
In vitro cartilage tissue engineering with 3D porous aqueous-derived silk scaffolds and mesenchymal stem cells. Biomaterials (2005) 2.02
Influence of macroporous protein scaffolds on bone tissue engineering from bone marrow stem cells. Biomaterials (2005) 1.94
Engineering bone-like tissue in vitro using human bone marrow stem cells and silk scaffolds. J Biomed Mater Res A (2004) 1.94
Activation of receptor activator of NF-kappaB ligand gene expression by 1,25-dihydroxyvitamin D3 is mediated through multiple long-range enhancers. Mol Cell Biol (2006) 1.92
1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts. J Bone Miner Res (2004) 1.90
Water-insoluble silk films with silk I structure. Acta Biomater (2009) 1.85
Silk microspheres for encapsulation and controlled release. J Control Release (2006) 1.81
Bioactive silk protein biomaterial systems for optical devices. Biomacromolecules (2008) 1.79
Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome. PLoS One (2011) 1.75
Growth factor gradients via microsphere delivery in biopolymer scaffolds for osteochondral tissue engineering. J Control Release (2008) 1.72
The human transient receptor potential vanilloid type 6 distal promoter contains multiple vitamin D receptor binding sites that mediate activation by 1,25-dihydroxyvitamin D3 in intestinal cells. Mol Endocrinol (2006) 1.70
Biomaterial films of Bombyx mori silk fibroin with poly(ethylene oxide). Biomacromolecules (2004) 1.70
Ultra-sensitive vibrational spectroscopy of protein monolayers with plasmonic nanoantenna arrays. Proc Natl Acad Sci U S A (2009) 1.69
Twenty-one millisecond pulsars in Terzan 5 using the Green Bank Telescope. Science (2005) 1.68
Porous silk fibroin 3-D scaffolds for delivery of bone morphogenetic protein-2 in vitro and in vivo. J Biomed Mater Res A (2006) 1.68
Human bone marrow stromal cell responses on electrospun silk fibroin mats. Biomaterials (2004) 1.67
Cartilage tissue engineering with silk scaffolds and human articular chondrocytes. Biomaterials (2006) 1.67
Role of membrane potential in the regulation of cell proliferation and differentiation. Stem Cell Rev (2009) 1.66
Enhancers located within two introns of the vitamin D receptor gene mediate transcriptional autoregulation by 1,25-dihydroxyvitamin D3. Mol Endocrinol (2006) 1.66
Silk fibroin microtubes for blood vessel engineering. Biomaterials (2007) 1.61
Human bone marrow-derived MSCs can home to orthotopic breast cancer tumors and promote bone metastasis. Cancer Res (2010) 1.61
Silk nanospheres and microspheres from silk/pva blend films for drug delivery. Biomaterials (2009) 1.59
Modification of silk fibroin using diazonium coupling chemistry and the effects on hMSC proliferation and differentiation. Biomaterials (2008) 1.59
Silk film biomaterials for cornea tissue engineering. Biomaterials (2008) 1.58
Silk polymer-based adenosine release: therapeutic potential for epilepsy. Biomaterials (2008) 1.57
Control of in vitro tissue-engineered bone-like structures using human mesenchymal stem cells and porous silk scaffolds. Biomaterials (2006) 1.56
Silk-based electrospun tubular scaffolds for tissue-engineered vascular grafts. J Biomater Sci Polym Ed (2008) 1.55
Genome-wide map of nuclear protein degradation shows NCoR1 turnover as a key to mitochondrial gene regulation. Cell (2013) 1.55
Mapping domain structures in silks from insects and spiders related to protein assembly. J Mol Biol (2004) 1.53
Two-photon microscopy for non-invasive, quantitative monitoring of stem cell differentiation. PLoS One (2010) 1.52
Bayesian analysis of signaling networks governing embryonic stem cell fate decisions. Bioinformatics (2004) 1.52
Electrospun silk biomaterial scaffolds for regenerative medicine. Adv Drug Deliv Rev (2009) 1.52
In vitro evaluation of electrospun silk fibroin scaffolds for vascular cell growth. Biomaterials (2008) 1.51
Native-sized recombinant spider silk protein produced in metabolically engineered Escherichia coli results in a strong fiber. Proc Natl Acad Sci U S A (2010) 1.51
Vortex-induced injectable silk fibroin hydrogels. Biophys J (2009) 1.50
Role of adult mesenchymal stem cells in bone tissue engineering applications: current status and future prospects. Tissue Eng (2005) 1.50
Engineered vascularized bone grafts. Proc Natl Acad Sci U S A (2010) 1.47
Tissue-engineered bone serves as a target for metastasis of human breast cancer in a mouse model. Cancer Res (2007) 1.46
Cartilage-like tissue engineering using silk scaffolds and mesenchymal stem cells. Tissue Eng (2006) 1.45
Bone tissue engineering with premineralized silk scaffolds. Bone (2008) 1.43
Relationships between mechanical properties and extracellular matrix constituents of the cervical stroma during pregnancy. Semin Perinatol (2009) 1.42
Self-assembly of genetically engineered spider silk block copolymers. Biomacromolecules (2009) 1.42
Mechanisms of silk fibroin sol-gel transitions. J Phys Chem B (2006) 1.41
Generation of functionally competent and durable engineered blood vessels from human induced pluripotent stem cells. Proc Natl Acad Sci U S A (2013) 1.41
Human bone marrow stromal cell and ligament fibroblast responses on RGD-modified silk fibers. J Biomed Mater Res A (2003) 1.40
Controlling silk fibroin particle features for drug delivery. Biomaterials (2010) 1.39
Retracted Stabilization of vaccines and antibiotics in silk and eliminating the cold chain. Proc Natl Acad Sci U S A (2012) 1.39
Silk materials--a road to sustainable high technology. Adv Mater (2012) 1.38
Silicon electronics on silk as a path to bioresorbable, implantable devices. Appl Phys Lett (2009) 1.38
Nanolayer biomaterial coatings of silk fibroin for controlled release. J Control Release (2007) 1.38
Spider silks and their applications. Trends Biotechnol (2008) 1.37
Membrane potential controls adipogenic and osteogenic differentiation of mesenchymal stem cells. PLoS One (2008) 1.37
Silk-based delivery systems of bioactive molecules. Adv Drug Deliv Rev (2010) 1.37
Biomaterials derived from silk-tropoelastin protein systems. Biomaterials (2010) 1.36
Biomaterials for the development of peripheral nerve guidance conduits. Tissue Eng Part B Rev (2011) 1.35
Electrogelation for protein adhesives. Adv Mater (2010) 1.34
Silk fibroin biomaterials for controlled release drug delivery. Expert Opin Drug Deliv (2011) 1.34
Novel nanocomposites from spider silk-silica fusion (chimeric) proteins. Proc Natl Acad Sci U S A (2006) 1.34
Biomaterial coatings by stepwise deposition of silk fibroin. Langmuir (2005) 1.34
Genetic engineering of fibrous proteins: spider dragline silk and collagen. Adv Drug Deliv Rev (2002) 1.33
Effect of processing on silk-based biomaterials: reproducibility and biocompatibility. J Biomed Mater Res B Appl Biomater (2011) 1.32
Matrix metalloproteinases and their clinical applications in orthopaedics. Clin Orthop Relat Res (2004) 1.32
Can tissue engineering concepts advance tumor biology research? Trends Biotechnol (2010) 1.32
Mechanism of enzymatic degradation of beta-sheet crystals. Biomaterials (2009) 1.30
Stabilization and release of enzymes from silk films. Macromol Biosci (2010) 1.30
In vitro 3D model for human vascularized adipose tissue. Tissue Eng Part A (2009) 1.29
Mandibular repair in rats with premineralized silk scaffolds and BMP-2-modified bMSCs. Biomaterials (2009) 1.29